Susceptibility to anti-glomerular basement membrane disease and goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice

Journal of Clinical Investigation

Volumn 100, Issue 9, 1997, Pages 2263-2275

  Kalluri, Raghuram ^a   Danoff, Theodore M ^a   Okada, Hirokazu ^a   Neilson, Eric G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anti basement membrane disease; Goodpasture syndrome; Major histocompatibility complex; Type IV collagen; 3(IV) NC1

Indexed keywords

COLLAGEN TYPE 4; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOLESCENT; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; GLOMERULONEPHRITIS; GOODPASTURE SYNDROME; LUNG HEMORRHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030704301     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119764     Document Type: Article

References (67)

1. Morrison, K.E., M. Mariyama, T.L. Yang-Feng, and S.T. Reeders. 1991. Sequence and localization of a partial cDNA encoding the human α3 chain of type IV collagen. Am. J. Hum. Genet. 49:545-554.
2. Kalluri, R., F.A. Shield, P. Todd, B.G. Hudson, and E.G. Neilson. 1997. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome increasing susceptibility to endoproteolysis. J. Clin. Invest. 99: 2470-2478.
3. Hudson, B.G., S.T. Reeders, and K. Tryggvason. 1993. Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J. Biol. Chem. 268:26033-26036.
4. Meyers, C.M., R. Kalluri, and E.G. Neilson. 1997. Anti-basement membrane antibodies in Goodpasture syndrome. In Immunologic Renal Diseases. E.G. Neilson and W.C. Couser, editors. Lippincott-Raven Publishers, New York. 959-975.
5. Kalluri, R., L.P. van den Heuvel, H.J. Smeets, C.H. Schroder, H.H. Lemmink, A. Boutaud, E.G. Neilson, and B.G. Hudson. 1995. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome. Kidney Int. 47(4):1199-1204.
6. D'Apice, A.J.F., P. Kincaid-Smith, G.J. Becker, M.G. Loughhead, J.W. Freeman, and J.M. Sands. 1978. Goodpasture's syndrome in identical twins. Ann. Intern. Med. 88:61-62.
7. Gossain, V.V., A.R. Gerstein, and A.W. Janes. 1972. Goodpasture's syndrome: a familial occurrence. Am. Rev. Respir. Dis. 105:621-624.
8. Rees, A.J., D.K. Peters, N. Amos, K.I. Welch, and J.R. Batchelor. 1984. The influence of HLA-linked genes on the severity of anti-GBM antibody-mediated nephritis. Kidney Int. 26:444-450.
9. Huey, B., K. McCormick, J. Crapper, C. Ratliff, B.W. Colombe, M.R. Garovoy, and C.B. Wilson. 1993. Associations of HLA-DSR and HLA-DQ types with anti-GBM nephritis by sequence-specific oligonucleotides probe hybridization. Kidney Int. 44:307-312.
10. Kalluri, R., M.J. Sun, B.G. Hudson, and E.G. Neilson. 1996. The Goodpasture autoantigen: structural delineation of two immunologically privileged epitopes on α3(IV) chain of type IV collagen. J. Biol. Chem. 271:9062-9068.
11. Kalluri, R., S. Gunwar, S.T. Reeders, K.C. Morrision, M. Mariyama, K.E. Ebner, M.E. Noelken, and B.G. Hudson. 1991. Goodpasture syndrome: localization of the epitope for the autoantibodies to the carboxyl-terminal region of the α3(IV) chain of basement membrane collagen. J. Biol. Chem. 266: 24018-24024.
12. Merkel, F., R. Kalluri, M. Marx, U. Enders, E.G. Neilson, H.G. Rammensee, B.G. Hudson, and M. Weber. 1995. Autoreactive T-cells in Goodpasture syndrome recognize the N-terminal NC1 domain of the α3 chain of type IV collagen. Kidney Int. 49:1127-1129.
13. Derry, C.J., C.N. Ross, G. Lombardi, P.D. Mason, A.J. Rees, R.I. Lechler, and C.D. Pusey. 1995. Analysis of T cell responses to the autoantigen in Goodpasture's disease. Clin. Exp. Immunol. 100:262-268.
14. Lerner, R.A., and F.J. Dixon. 1966. Transfer of ovine experimental allergic glomerulonephritis (EAG) with serum. J. Exp. Med. 124:431-442.
15. Salant, D.J., and A.V. Cybulsky. 1988. Experimental glomerulonephritis. Methods Enzymol. 162:421-461.
16. Wilson, C.B. 1997. Animal models for glomerulonephritis. In Immunologic Renal Diseases. E.G. Neilson and W.C. Couser, editors. Lippincott-Raven Publishers, New York. 729-804.
17. Couser, W.G., C. Darby, D.J. Salant, S. Adler, M.M. Stilmant, and L.M. Lowenstein. 1985. Anti-GBM antibody-induced proteinuria in isolated perfused rat kidney. Am. J. Physiol. 249:F241-F250.
18. Madaio, M.P., D.J. Salant, S. Adler, C. Darby, and W.G. Couser. 1984. Effect of antibody charge and concentration on deposition of antibody to glomerular basement membrane. Kidney Int. 26:397-403.
19. Hill, P.A., H.Y. Lan, D.J. Nikolic-Paterson, and R.C. Atkins. 1994. The ICAM-1/LFA-1 interaction in glomerular leukocytic accumulation in anti-GBM glomerulonephritis. Kidney Int. 45:700-708.
20. Nishikawa, K., Y.J. Guo, M. Miyasaka, T. Tamatani, A.B. Collins, M.S. Sy, R.T. McCluskey, and G. Andres. 1993. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis. J. Exp. Med. 177:667-677.
21. Nishikawa, K., P.S. Linsley, A.B. Collins, I. Stamenkovic, R.T. McCluskey, and G. Andres. 1994. Effect of CTLA-4 chimeric protein on rat autoimmune anti-glomerular basement membrane glomerulonephritis. Eur. J. Immunol. 24:1249-1254.
22. Wilson, C.B. 1996. Renal response to immunological glomerular injury. In The Kidney, Volume II. B. Brenner, editor. W.B. Saunders Company, Philadelphia. 1253-1391.
23. Avasthi, P.S., P. Avasthi, S. Tokuda, R.E. Anderson, and R.C. Williams. 1971. Experimental glomerulonephritis in the mouse. Clin. Exp. Immunol. 9: 667-676.
24. Bolton, W.K., F.R. Benton, and B.C. Sturgill. 1978. Autoimmune glomerulotubular nephropathy in mice. Clin. Exp. Immunol. 33:463-473.
25. Wick, G., H. von der Mark, H. Dietrich, and R. Timpl. 1986. Globular domain of basement membrane collagen induces autoimmune pulmonary lesions in mice resembling human Goodpasture disease. Lab. Invest. 55:308-317.
26. Kalluri, R., C.B. Wilson, M. Weber, S. Gunwar, A.M. Chonko, E.G. Neilson, and B.G. Hudson. 1995. Identification of the α3(IV) chain of type IV collagen as the common autoantigen in anti-basement membrane disease and Goodpasture syndrome. J. Am. Soc. Nephrol. 6:1178-1185.
27. Kalluri, R., V.H. Gattone, Jr., M.E. Noelken, and B.G. Hudson. 1994. The α3(IV) chain of type IV collagen induces autoimmune Goodpasture syndrome. Proc. Natl. Acad. Sci. USA. 91:6201-6205.
28. Mombaerts, P., E. Mizoguchi, M.J. Grunsby, L.H. Glimcher, A.K. Bhan, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 75:275-282.
29. Neilson, E.G., and S.M. Phillips. 1982. Murine interstitial nephritis. I. Analysis of disease susceptibility and its relationship of pleiomorphic gene products defining both immune-response genes and a restrictive requirement for cytotoxic T cells at H-2K. J. Exp. Med. 155:1075-1085.
30. Kahsai, T., G. Enders, S. Gunwar, R. Kalluri, J. Zhou, and B. Hudson. 1997. Seminiferous tubule basement membrane: composition of type IV collagen chains, and abundance of the α3(IV) chain, the Goodpasture antigen and alport alloantigen. J. Biol. Chem. 272:17023-17032.
31. Gunwar, S., F. Ballester, R. Kalluri, J. Timoneda, A.M. Chonko, S.J. Edwards, M.E. Noelken, and B.G. Hudson. 1991. Glomerular basement membrane: identification of dimeric subunits of the noncollagenous domain (hexamer) of collagen IV and the Goodpasture antigen. J. Biol. Chem. 266:15318-15324.
32. Zakheim, B., E. McCafferty, S.M. Phillips, M. Clayman, and E.G. Neilson. 1984. Murine interstitial nephritis. II. The adoptive transfer of disease with immune T lymphocytes produces a phenotypically complex interstitial lesion. J. Immunol. 133:234-239.
33. Strutz, F., H. Okada, C.W. Lo, T. Danoff, R.L. Carone, J.E. Tomaszewski, and E.G. Neilson. 1995. Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 130:393-405.
34. Kalluri, R., E. Melendez, W.K. Rumpf, K. Sattler, G.A. Muller, F. Strutz, and E.G. Neilson. 1996. Specificity of circulating and tissue-bound autoantibodies in Goodpasture syndrome. Proc. Assoc. Am. Physicians. 108:134-139.
35. Chen, Y., and H. Weiner. 1996. Dose-dependent activation and deletion of antigen-specific T cells following oral tolerance. Ann. NY Acad. Sci. 778:111-121.
36. Chen, Y., V.K. Kuchroo, J. Inobe, D.A. Hafler, and H.L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science (Wash. DC). 265:1237-1240.
37. Jones, P.P., D.B. Murphy, and H.O. McDevitt. 1981. Variable synthesis and expression of Eα and Ae (Eβ). Ia polypeptide chains in mice of different H-2 haplotypes. Immunogenetics. 12:321-329.
38. Neilson, E.G., R. Kalluri, M.J. Sun, S. Gunwar, T. Danoff, M. Mariyama, J.C. Myers, S.T. Reeders, and B.G. Hudson. 1993. Specificity of Goodpasture autoantibodies for the recombinant noncollagenous domains of human type IV collagen. J. Biol. Chem. 268:8402-8405.
39. Riblet, R., and P.H. Brodeur. 1986. The Igh-V gene repertoire of the mouse. Mt. Sinai J. Med. 53:170-174.
40. Riblet, R., A. Tutter, and P. Brodeur. 1986. Polymorphism and evolution of Igh-V gene families. Curr. Top. Microbiol. Immunol. 127:168-172.
41. + effector T cell that mediates destructive tubulointerstitial injury. J. Immunol. 136:526-531.
42. Seder, R.A., and W.E. Paul. 1994. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12:635-674.
43. Weiner, H.L., A. Friedman, A. Miller, S.J. Khoury, A. Al-Sabbagh, L. Santos, M. Sayegh, R.B. Nussenblatt, D.E. Trentham, and D.A. Hafler. 1994. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:809-837.
44. Sosroseno, W. 1995. A review of the mechanisms of oral tolerance and immunotherapy. J. R. Soc. Med. 88:14-17.
45. Chen, Y., J. Inobe, and H.L. Weiner. 1995. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. J. Immunol. 155:910-916.
46. Akselband, Y., T.L. Hoffer, P.A. Nelson, P.A. Gonnella, and H.L. Weiner. 1996. Local and systemic immune responses in SJL/J mice during prolonged oral myelin basic protein administration. Ann. NY Acad. Sci. 778:358-361.
47. Weiner, H.L. 1994. Oral tolerance. Proc. Natl. Acad Sci. USA. 91: 10762-10765.
48. Steblay, R.W. 1962. Glomerulonephritis induced in sheep by injections of heterologous glomerular basement membrane and Freund's complete adjuvant. J. Exp. Med. 116:253-271.
49. Kalluri, R., S. Pettrides, C.B. Wilson, J.E. Tomaszewski, H.I. Palevsky, M.A. Grippi, M. Madaio, and E.G. Neilson. 1996. Anti-α1(IV) collagen autoantibodies associated with lung adenocarcinoma presenting as the Goodpasture syndrome. Ann. Intern. Med. 124:651-653.
50. Germain, R.N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T-lymphocyte activation. Cell. 76:287-300.
51. Janeway, C.A., Jr., and K. Bottomly. 1994. Signals and signs for lymphocyte responses. Cell. 76:275-285.
52. Bolton, W.K., F.L. Tucker, and B.C. Sturgill. 1984. New avian model of experimental glomerulonephritis consistent with mediation by cellular immunity. Nonhumorally mediated glomerulonephritis in chickens. J. Clin. Invest. 73: 1263-1276.
53. Kelso, A. 1995. Th1 and Th2 subsets: paradigm lost? Immunol. Today. 16:374-379.
54. Romagnani, S. 1995. Biology of human TH1 and TH2 cells. J. Clin. Immunol. 15:121-129.
55. Finkelman, F.D., J. Holmes, I. Katona, J.F. Urban, M.P. Beckman, L.S. Park, K.A. Schooley, R.L. Coffman, T.R. Mosmann, and W.E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303-334.
56. Constant, S.L., and K. Bottomly. 1997. Induction of the Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15: 297-322.
57. + T cells through IL-12 produced by listeria-induced macrophages. Science (Wash. DC). 260:547-550.
58. Pfeiffer, C., J. Murray, J. Madri, and K. Bottomly. 1991. Selective activation of Th1-and Th2-like cells in vivo - response to human collagen IV. Immunol. Rev. 123:65-84.
59. Perez, V.L., J.A. Lederer, A.H. Lichtman, and A.K. Abbas. 1995. Stability of Th1 and Th2 populations. Int. Immunol. 7:869-875.
60. + T cell subset activation. J. Exp. Med. 170:2135-2140.
61. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181:1569-1574.
62. 5): evidence for effects of polymer handling and gene dosage. J. Immunol. 123: 272-277.
63. + T cells to enhance priming for IFNγ production and diminishes IL-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA. 90:10188-10193.
64. Guler, M.L., J.D. Gorham, C.S. Hsieh, A.J. Mackey, R.G. Steen, W.F. Dietrich, and K.M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science (Wash. DC). 271:984-987.
65. Noben-Trauth, N., P. Kropf, and I. Muller. 1996. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science (Wash. DC). 271: 987-990.
66. Sayegh, M.H., S.J. Khoury, W.W. Hancock, H.L. Weiner, and C.B. Carpenter. 1996. Mechanisms of oral tolerance by MHC peptides. Ann. NY Acad. Sci. 778:338-345.
67. Gunwar, S., J. Saus., M.E. Noelken, and B.G. Hudson. 1990. Glomerular basement membrane. Identification of a fourth chain, α4, of type IV collagen. J. Biol. Chem. 265:5466-5469.